Ro 60-0175 fumarate,(αS)-6-Chloro-5-fluoro-α-methyl-1H-indole-1-ethanaminefumarate

Ro60-0175 is a drug developed by Hoffmann–La Roche, which has applications in scientific research. It acts as a potent and selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes, with good selectivity over the closely related 5-HT2A subtype, and little or no affinity at other receptors.